Signaling pathways
-
BA6992 GNE-0439Summary: GNE-0439 is a novel selective inhibitor. - BA6993 PF-04885614Summary: PF-04885614 is an effective inhibitor, see US2018328915 for details.
- BA6994 Nav1.7-IN-3Summary: Nav1.7-IN-3 is a selective, orally active voltage-gated sodium channel inhibitor.
- BA6995 PF-05241328Summary: PF-05241328 is a potent, selective inhibitor of human voltage-dependent sodium channels.
- BA6996 AZ194Summary: AZ194 is a first-in-class orally active interaction inhibitor and suppressor (=1.2 μM).
- BA6997 PF-05198007Summary: PF-05198007 is a potent, orally active, selective inhibitor of acrylamide.
- BA6998 ABBV-318Summary: ABBV-318 is an effective blocker.
- BA6999 GNE-131Summary: GNE-131 is a potent and selective inhibitor of the human sodium channel NaV1.7.
- BA7000 XEN907Summary: XEN907 is a potent spirohydroxyindole blocker.
- BA7001 3-DeoxyaconitineSummary: 3-Deoxyaconitine is a diterpenoid alkaloid.